Terms: = Pancreatic cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
27 results:
1. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials.
Liu S; Li H; Xue Y; Yang L
PLoS One; 2023; 18(9):e0290888. PubMed ID: 37672511
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of characteristics and outcomes of young-onset versus average onset pancreatico-biliary adenocarcinoma.
Jayakrishnan T; Nair KG; Kamath SD; Wei W; Estfan BN; Krishnamurthi SS; Khorana AA
Cancer Med; 2023 Mar; 12(6):7327-7338. PubMed ID: 36621839
[TBL] [Abstract] [Full Text] [Related]
4. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract] [Full Text] [Related]
5. Intraductal tubulopapillary neoplasms of the bile ducts: identity, clinicopathologic characteristics, and differential diagnosis of a distinct entity among intraductal tumors.
Pehlivanoglu B; Adsay V
Hum Pathol; 2023 Feb; 132():12-19. PubMed ID: 35934108
[TBL] [Abstract] [Full Text] [Related]
6. Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study.
Shen J; Shen H; Ke L; Chen J; Dang X; Liu B; Hua Y
Front Immunol; 2022; 13():815575. PubMed ID: 35173728
[TBL] [Abstract] [Full Text] [Related]
7. [Comparison of long-term outcomes between endoscopic submucosal dissection and surgical resection for early gastric cancer with undifferentiated histology].
Zhang QR; Guo CG; Zhang YM; Xue LY; He S; Dou LZ; Liu Y; Shi L; Zhao DB; Wang GQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):413-419. PubMed ID: 34000770
[No Abstract] [Full Text] [Related]
8. The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center.
Quero G; Salvatore L; Fiorillo C; Bagalà C; Menghi R; Maria B; Cina C; Laterza V; Di Stefano B; Maratta MG; Ribelli M; Galiandro F; Mattiucci GC; Brizi MG; Genco E; D'Aversa F; Zileri L; Attili F; Larghi A; Perri V; Inzani F; Gasbarrini A; Valentini V; Costamagna G; Manfredi R; Tortora G; Alfieri S
ESMO Open; 2021 Feb; 6(1):100010. PubMed ID: 33399076
[TBL] [Abstract] [Full Text] [Related]
9. Systematic review and updated network meta-analysis comparing open, laparoscopic, and robotic pancreaticoduodenectomy.
Aiolfi A; Lombardo F; Bonitta G; Danelli P; Bona D
Updates Surg; 2021 Jun; 73(3):909-922. PubMed ID: 33315230
[TBL] [Abstract] [Full Text] [Related]
10. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
[TBL] [Abstract] [Full Text] [Related]
11. Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize treatment Selection.
Park W; Chen J; Chou JF; Varghese AM; Yu KH; Wong W; Capanu M; Balachandran V; McIntyre CA; El Dika I; Khalil DN; Harding JJ; Ghalehsari N; McKinnell Z; Chalasani SB; Makarov V; Selenica P; Pei X; Lecomte N; Kelsen DP; Abou-Alfa GK; Robson ME; Zhang L; Berger MF; Schultz N; Chan TA; Powell SN; Reis-Filho JS; Iacobuzio-Donahue CA; Riaz N; O'Reilly EM
Clin Cancer Res; 2020 Jul; 26(13):3239-3247. PubMed ID: 32444418
[TBL] [Abstract] [Full Text] [Related]
12. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Pishvaian MJ; Blais EM; Brody JR; Lyons E; DeArbeloa P; Hendifar A; Mikhail S; Chung V; Sahai V; Sohal DPS; Bellakbira S; Thach D; Rahib L; Madhavan S; Matrisian LM; Petricoin EF
Lancet Oncol; 2020 Apr; 21(4):508-518. PubMed ID: 32135080
[TBL] [Abstract] [Full Text] [Related]
13. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.
Philip PA; Lacy J; Portales F; Sobrero A; Pazo-Cid R; Manzano Mozo JL; Kim EJ; Dowden S; Zakari A; Borg C; Terrebonne E; Rivera F; Sastre J; Bathini V; López-Trabada D; Asselah J; Saif MW; Shiansong Li J; Ong TJ; Nydam T; Hammel P
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):285-294. PubMed ID: 31953079
[TBL] [Abstract] [Full Text] [Related]
14. Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies.
Abdel-Rahman O
Clin Transl Oncol; 2019 Jun; 21(6):810-816. PubMed ID: 30465184
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic performance of contrast-enhanced ultrasound for pancreatic neoplasms: A systematic review and meta-analysis.
Li XZ; Song J; Sun ZX; Yang YY; Wang H
Dig Liver Dis; 2018 Feb; 50(2):132-138. PubMed ID: 29162410
[TBL] [Abstract] [Full Text] [Related]
16. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the treatment of Malignant Obstructive Jaundice.
Xu X; Li J; Wu J; Zhu R; Ji W
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):206-217. PubMed ID: 29075881
[TBL] [Abstract] [Full Text] [Related]
17. Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery?
Puri PM; Watkins AA; Kent TS; Maggino L; Jeganathan JG; Callery MP; Drebin JA; Vollmer CM
J Gastrointest Surg; 2018 Jan; 22(1):88-97. PubMed ID: 28875275
[TBL] [Abstract] [Full Text] [Related]
18. A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.
Kulke MH; Ruszniewski P; Van Cutsem E; Lombard-Bohas C; Valle JW; De Herder WW; Pavel M; Degtyarev E; Brase JC; Bubuteishvili-Pacaud L; Voi M; Salazar R; Borbath I; Fazio N; Smith D; Capdevila J; Riechelmann RP; Yao JC
Ann Oncol; 2017 Jun; 28(6):1309-1315. PubMed ID: 28327907
[TBL] [Abstract] [Full Text] [Related]
19. The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study.
Shin SH; Kim HJ; Hwang DW; Lee JH; Song KB; Jun E; Shim IK; Hong SM; Kim HJ; Park KM; Lee YJ; Kim SC
Oncotarget; 2017 Mar; 8(11):17945-17959. PubMed ID: 28160547
[TBL] [Abstract] [Full Text] [Related]
20. Biliary fistula after liver resection: central role of intraoperative perihepatic drain.
Barabino M; Gatti A; Santambrogio R; Centonze L; Virdis M; Angiolini MR; Luigiano C; Opocher E
Minerva Chir; 2016 Dec; 71(6):353-359. PubMed ID: 27787479
[TBL] [Abstract] [Full Text] [Related]
[Next]
